- Home
- TCMD vs MRVI Comparison
TCMD vs MRVI Comparison
Compare TCMD & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCMD
- MRVI
- Stock Information
- Founded
- TCMD 1995
- MRVI 2014
- Country
- TCMD United States
- MRVI United States
- Employees
- TCMD N/A
- MRVI N/A
- Industry
- TCMD Medical/Dental Instruments
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- TCMD Health Care
- MRVI Health Care
- Exchange
- TCMD Nasdaq
- MRVI Nasdaq
- Market Cap
- TCMD 337.0M
- MRVI 347.5M
- IPO Year
- TCMD 2016
- MRVI 2020
- Fundamental
- Price
- TCMD $13.60
- MRVI $2.16
- Analyst Decision
- TCMD Hold
- MRVI Hold
- Analyst Count
- TCMD 2
- MRVI 10
- Target Price
- TCMD $18.00
- MRVI $7.59
- AVG Volume (30 Days)
- TCMD 215.0K
- MRVI 3.8M
- Earning Date
- TCMD 05-05-2025
- MRVI 05-07-2025
- Dividend Yield
- TCMD N/A
- MRVI N/A
- EPS Growth
- TCMD N/A
- MRVI N/A
- EPS
- TCMD 0.70
- MRVI N/A
- Revenue
- TCMD $292,984,000.00
- MRVI $259,185,000.00
- Revenue This Year
- TCMD $10.71
- MRVI N/A
- Revenue Next Year
- TCMD $8.80
- MRVI $14.59
- P/E Ratio
- TCMD $18.89
- MRVI N/A
- Revenue Growth
- TCMD 6.76
- MRVI N/A
- 52 Week Low
- TCMD $11.12
- MRVI $2.07
- 52 Week High
- TCMD $21.10
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- TCMD 42.96
- MRVI 28.06
- Support Level
- TCMD $12.69
- MRVI $2.07
- Resistance Level
- TCMD $13.94
- MRVI $2.43
- Average True Range (ATR)
- TCMD 0.42
- MRVI 0.20
- MACD
- TCMD 0.11
- MRVI 0.05
- Stochastic Oscillator
- TCMD 59.48
- MRVI 14.06
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.